Cargando…
A novel ROCK inhibitor: off-target effects of metformin
In drug discovery, most small molecules cannot cross many stages, only a few can become drug candidates. Once the drug molecule is approved and marketed, nontarget effects that are not easily distinguishable from the actual target of the drugs might be evaluated. This situation restricts the treatme...
Autores principales: | ÖZDEMİR, Aysun, ARK, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877715/ https://www.ncbi.nlm.nih.gov/pubmed/33597820 http://dx.doi.org/10.3906/biy-2004-12 |
Ejemplares similares
-
Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activities
por: Patel, Ronil A., et al.
Publicado: (2013) -
Dual Inhibitors of PARPs and ROCKs
por: Antolín, Albert A., et al.
Publicado: (2018) -
On and off the rocks: persistence and ecological diversification in a tropical Australian lizard radiation
por: Oliver, Paul M., et al.
Publicado: (2019) -
Metformin turns off the metabolic switch of pancreatic cancer
por: Deschênes-Simard, Xavier, et al.
Publicado: (2019) -
The therapeutic effects of Rho-ROCK inhibitors on CNS disorders
por: Kubo, Takekazu, et al.
Publicado: (2008)